Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$14,196,037
+$764,095 QoQ
Shares Held
110,475
-1.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#622
of 3,768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. MRK ranks #1 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,196,037 | 110,475 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $13,431,942 | 111,663 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $11,740,068 | 111,534 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $9,495,756 | 113,139 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,147,096 | 115,552 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $11,008,884 | 122,648 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $12,970,102 | 130,379 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,286,311 | 134,610 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,256,729 | 139,392 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $15,265 | 140,020 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $15,264,980 | 140,020 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $14,546,937 | 141,301 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $16,487,846 | 142,888 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,769,444 | 148,223 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,566,499 | 149,315 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $12,851,515 | 149,228 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $13,333,977 | 146,254 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $11,301,794 | 147,466 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,011,726 | 146,608 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,255,418 | 144,727 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $12,202,582 | 158,290 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $12,830,978 | 156,858 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,946,344 | 156,074 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,917,563 | 154,113 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,909,383 | 154,788 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||